Market Research Logo
Region: Africa
Category: Life Sciences

Africa Life Sciences

(648 reports matching your criteria)
  • Sub-Saharan Africa Medical Devices Q3 2018

    ... will remain reliant on imports andinternational aid and funding, therefore multinationals will continue to strengthen their presence. Consumables will record thefastest CAGR in weighted local currency terms, while orthopaedics & prosthetics will register the slowest ... Read More

  • Botswana Pharmaceuticals & Healthcare Q3 2018

    ... by a weakregulatory environment, small pensionable population and a highly ruralised community. Generic medicines will continue todominate the market, with patented drugmakers choosing to operate in larger markets in the region such as South African. Read More

  • Gabon Pharmaceuticals & Healthcare Q3 2018

    ... diseases will remain significant, we expect the increasein the incidence of non-communicable diseases to be the key driver of longer-term pharmaceutical market's trajectory. Commercialopportunities will mostly remain in the generic segment, given the rising role ... Read More

  • Sub-Saharan Africa Pharmaceuticals & Healthcare Q3 2018

    ... procedures, a lack of enforced patent laws, and ageneral lack of transparency that ensures the region lags behind others globally for revenue-earning opportunities. Despite this, theregion's pharmaceutical markets will continue to provide long-term opportunities for ... Read More

  • Tunisia Pharmaceuticals & Healthcare Q3 2018

    ... expect it to retain this position over the long term. Highlighting themarket's longer-term potential, some multinational drugmakers have shown their willingness to do business in the country, thoughthe majority choose to operate indirectly to minimise ... Read More

  • Ethiopia Pharmaceuticals & Healthcare Q3 2018

    ... multinational drugmakers will remaindecidedly difficult to exploit as the lack of intellectual property protection, weak healthcare system, and abundance of povertyremain entrenched. Ethiopia certainly has the potential to improve its pharmaceutical manufacturing base, largely supported ... Read More

  • Ghana Pharmaceuticals & Healthcare Q3 2018

    ... the market, somewhat limiting high-value commercial opportunities. We believethat Ghana’s ambition of becoming the strategic hub for pharmaceutical investment in the ECOWAS region as a highly ambitioustarget, with Nigeria’s dominance as the primary medicine manufacturer ... Read More

  • Namibia Pharmaceuticals & Healthcare Q3 2018

    Namibia Pharmaceuticals & Healthcare Q3 2018 BMI View: The small overall size of the market will continue to discourage more concerted efforts by multinationals to enter Read More

  • Mozambique Pharmaceuticals & Healthcare Q3 2018

    ... – and poor regulatory enforcement. Although agrowing population, high disease burden and some efforts by the government to improve overall healthcare will support demandfor generic medicines, albeit limited, Mozambique will remain one of the least ... Read More

  • Nigeria Pharmaceuticals & Healthcare Q3 2018

    ... in line with increasinggovernment support, although the benefits are unlikely to be realised over the near-term. The majority of multinational drugmakerswill continue to opt for an indirect presence as the business climate remains decidedly difficult ... Read More

  • Tanzania Pharmaceuticals & Healthcare Q3 2018

    ... healthcare system and lowlevels of affordability. However, we forecast the pharmaceutical market to expand rapidly over the coming years, albeit from a smallbase compared to developed markets, spurred on by a rapidly growing population and ... Read More

  • Mauritius Pharmaceuticals & Healthcare Q3 2018

    ... Healthcare infrastructureexpansion and the rising burden of chronic diseases will ensure that demand for treatment remains high. Despite short-termeconomic headwinds, Mauritius’s long-term growth outlook is broadly positive, as the island is moving towards becoming atranshipment ... Read More

  • Egypt Medical Devices Q3 2018

    ... is enormous potential for growth as the country has the largest population in the Arabworld. Improving political and economic fundamentals will support long-term market growth, revised slightly downwards followingrecent economic turbulence and the massive depreciation ... Read More

  • Cameroon Pharmaceuticals & Healthcare Q3 2018

    ... rolling out of this health financing mechanism will proceed at a slowpace, however, given the current low level of health system development. More broadly, sustained economic growth bodes well forpharmaceutical spending growth over the medium ... Read More

  • Morocco Medical Devices Q3 2018

    ... over our forecast period both in local currency and USdollar terms, together with the expansion of universal health insurance coverage, external funding and increasing investment inhealthcare infrastructure. However, the market will remain heavily import dependent. Read More

  • Kenya Pharmaceuticals & Healthcare Q3 2018

    ... include the commitment to ensure universal healthcare coverage,and the rising disease burden, both in terms of non- and communicable conditions. Additionally, Kenyans are some of the mostprolific users of internet, which bodes well for the ... Read More

  • Angola Pharmaceuticals & Healthcare Report Q3 2018

    ... demographic, per capita spending on medicines will remainsignificantly low over our forecast period. However, overall growth of the market will be supported by a rapidly growing populationcoupled with small but steady improvements to healthcare access ... Read More

  • Nigeria Medical Devices Report Q3 2018

    ... The market will benefit from an improved outlook for the economy and willremain almost entirely reliant on imports. The large population and highly underdeveloped healthcare sector offer huge long-termpotential, but chronic underfunding and the chaotic ... Read More

  • Ghana Medical Devices Report Q3 2018

    ... in both local currency and US dollar termsover the 2017-2022 period. Economic expansion, the large population and ongoing healthcare projects will benefit the market, butdecreasing health expenditure and limited domestic production will constrain market growth. Read More

  • Zambia Pharmaceuticals & Healthcare Report Q3 2018

    ... However, few opportunities exist from the perspective ofmultinational companies, given factors such as the low purchasing power and the wide-spread presence of counterfeit medicines.On the other hand, authorities' support for the reduction of reliance on ... Read More

  • Kenya Medical Devices Report Q3 2018

    ... terms due to the depreciation of the Kenyan shilling. The market will remain heavily reliant onimports due to domestic manufacturers focusing on basic consumables. The Equitable Division of Revenue Bill will benefitmanufacturers and healthcare providers. Read More

  • Free From in Egypt

    ... gluten or lactose, and attribute symptoms to other ailments. Moreover, even if consumers are aware that they have food allergies, it is often difficult for them to find free from products that meet their needs. ... Read More

  • Algeria Pharmaceuticals & Healthcare Report Q3 2018

    ... years. Algeria’s strategic geographicalposition and government incentives for investors will support the country’s long-term aspiration towards becoming a drugmanufacturing and export base. That said, slow progress in revising drug pricing regulations and import restrictions will ... Read More

  • Zimbabwe Pharmaceuticals & Healthcare Q2 2018

    ... thepublic healthcare sector received only minor contributions from the government, partly a result of growing public debt. Followingthe successful replacement of Mugabe with the more reform-minded President Emmerson Mnangagwa in late 2017, we hold amore ... Read More

  • Tanzania Pharmaceuticals & Healthcare Report Q2 2018

    ... over the coming years. However, we note that growth will bepartly due to inflationary pressures from a relatively low value base. The demand for high-value drugs will remain limited by itsunderdeveloped healthcare system and low ... Read More

< prev 1 3 4 5 6 7 8 9 10